Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 2 52-2, 2002, Pages

  Ardizzone, Timothy D ^a   Lu, Xiao Hong ^a   Dwyer, Donard S ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Glucose transporter; Hyperglycemia; Nimodipine; Verapamil

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DEOXYGLUCOSE; DILTIAZEM; EDETIC ACID; FLUNARIZINE; GALLOPAMIL; GLUCOSE; GLUCOSE TRANSPORTER; NIFEDIPINE; NIMODIPINE; OMEGA CONOTOXIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG STRUCTURE; GLUCOSE TRANSPORT; NERVE CELL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0036074130     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00451.2001     Document Type: Article

References (51)

1. Counteraction of nifedipine-induced hyperglycemia by metformin
2. Diltiazem and hyperglycemia-coma
3. Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine
4. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain
5. Mammalian passive glucose transporters: Members of an ubiquitous family of active and passive transport proteins
6. Detection of the GLUT3 facilitative glucose transporter in rat L6 muscle cells: Regulation by cellular differentiation, insulin and insulin-like growth factor-I
7. Diverse effects of calcium channel blockers on skeletal muscle glucose transport
8. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes
9. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics of glucose transport
10. Psychoactive drugs affect glucose transport and the regulation of glucose metabolism
11. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells
12. Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells
13. Attachment of PC12 cells to adhesion substratum induces the accumulation of glucose transporters and stimulates glucose metabolism
14. 3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats
15. Regulation of ionic currents in pheochromocytoma cells by nerve growth factor and dexamethasone
16. Calcium- and potassium-channel blockers interact with alpha-adrenoceptors
17. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists
18. Impairment of insulin secretion in man by nifedipine
19. Nifedipine overdose
20. Enhanced permeability to sugar associated with muscle contraction
21. Norepinephrine modulates high voltage-activated calcium channels in freshly dissociated rat nucleus tractus solitarii neurons
22. An assessment of zonisamide as an anti-epileptic drug
23. The general metabolism of the brain in vivo
24. 2+ and cPKC
25. Effects of calcium ionophore ionomycin on insulin-stimulated and basal glucose transport in muscle
26. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion
27. Glucose transporter proteins in brain
28. Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells
29. Molecular basis of drug interaction with L-type calcium channels
30. Purification and N-terminal sequencing of the high-affinity phenylalkylamine calcium antagonist binding protein from guinea-pig liver endoplasmic reticulum
31. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents
32. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons
33. Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses
34. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels
35. 2+ stores in myoblast fusion
36. Verapamil acute self-poisoning
37. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in conscious and anesthetized rat
38. Human red blood-cell calcium antagonist binding sites
39. A novel omega-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction
40. Amiloride selectively blocks the low threshold (T) calcium channel
41. Glucose transporter GLUT3 is targeted to secretory vesicles in neurons and PC12 cells
42. Coupling of insulin binding and insulin action on glucose transport in fat cells
43. Functional coupling between "R-type" calcium channels and insulin secretion in the insulinoma cell line INS-1
44. T-channel-selective calcium channel blockade: A promising therapeutic possibility, only preliminarily tested so far: A review of published data
45. 2-adrenoceptor stimulation
46. Improvement in mitochondrial dysfunction as a new surrogate efficiency measure of preclinical trial: Dose-response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury
47. Effect of calcium-channel agonists and antagonists on skeletal muscle sugar transport
48. The role of calcium in insulin stimulated glucose transport in 3T3-L1 cells
49. Role of dihydropyridine sensitive calcium channels in glucose transport in skeletal muscle
50. Diabetogenic effects of nifedipine